Current Antiretroviral Treatment Among People With Human Immunodeficiency Virus in the United States: Findings from the Centers for AIDS Research Network of Integrated Clinic Systems Cohort

Among 14 049 people with human immunodeficiency virus in care in 2019-2020, 96% were treated with antiretroviral therapy (ART). Current antiretroviral treatment patterns highlight high uptake of guideline-recommended ART regimens including second-generation integrase strand transfer inhibitors (dolu...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical infectious diseases 2022-09, Vol.75 (4), p.715-718
Hauptverfasser:	Ma, Jimmy, Nance, Robin M, Delaney, Joseph A C, Whitney, Bridget M, Bamford, Laura, Gravett, Ronnie M, Moore, Richard D, Napravnik, Sonia, Mayer, Kenneth H, Jacobson, Jeffrey M, Christopoulos, Katerina, Burkholder, Greer A, Keruly, Jeanne, Eron, Joseph J, Martin, Jeffrey, Cachay, Edward R, Saag, Michael S, Crane, Heidi M, Kitahata, Mari M
Format:	Artikel
Sprache:	eng
Schlagworte:	Acquired Immunodeficiency Syndrome - drug therapy Alanine - therapeutic use Anti-HIV Agents - therapeutic use Anti-Retroviral Agents - therapeutic use Brief Report Emtricitabine - therapeutic use Heterocyclic Compounds, 3-Ring - therapeutic use HIV HIV Infections - drug therapy Humans Tenofovir - therapeutic use United States
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Among 14 049 people with human immunodeficiency virus in care in 2019-2020, 96% were treated with antiretroviral therapy (ART). Current antiretroviral treatment patterns highlight high uptake of guideline-recommended ART regimens including second-generation integrase strand transfer inhibitors (dolutegravir and bictegravir) and tenofovir alafenamide, especially in antiretroviral-naive individuals initiating ART.
ISSN:	1058-4838 1537-6591
DOI:	10.1093/cid/ciac086